Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Similarly, a significant positive correlation was observed between the initiation of vitamin D supplementation and transfusion frequency [Spearman’s correlation coefficient = 0.246(0.116 to 0.368), p < 0.001].
Source: Association between timing of vitamin AD and vitamin D supplementation and number of blood transfusions. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Early vitamin AD supplementation reduces transfusion needs in preterm infants: a retrospective cohort study
Source: Article title.
Patients were stratified by supplementation timing (≤14 vs.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Early vitamin AD supplementation reduces transfusion needs in preterm infants: a retrospective cohort study
Cohort study · Frontiers in Nutrition · 2026
Original publication title
Early vitamin AD supplementation reduces transfusion needs in preterm infants: a retrospective cohort study
Copyright © 2026 Li, Ye, Tian, Zhou and Shen.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Anemia of prematurity (AOP) is a common condition, often necessitating transfusion therapy. Although vitamin AD deficiency has been linked to anemia pathogenesis, the effect of supplementation timing on transfusion needs remains unclear. This study investigates the association between the initiation timing of vitamin AD supplementation and the number of transfusions received in preterm infants.
Source: IntroductionAbstract: What methods does the paper describe?
In this retrospective cohort study, we included 226 preterm infants (gestational age <37 weeks) who received both blood transfusions and vitamin AD supplementation in a neonatal intensive care unit (2018 to 2022). The association was assessed using Spearman correlation. Segmented Poisson regression compared transfusion incidence rates before and after supplementation, controlling for hospitalization timeline. A conditional Cox model (Anderson-Gill) evaluated the impact on subsequent transfusion risk, adjusting for covariates. Patients were stratified by supplementation timing (≤14 vs. >14 days), with propensity score matching applied to balance groups.
Independent factors were identified using generalized linear models.
Source: MethodsAbstract: Results
The timing of vitamin AD initiation was positively correlated with transfusion number [Spearman’s ρ = 0.200(0.068 to 0.326), p = 0.003], an association that remained significant in subgroups including infants 28 to 37 weeks and those without complications. Multivariable analysis identified supplementation timing as an independent risk factor for transfusion frequency [β = 0.016(0.007 to 0.025), p < 0.001]. Segmented Poisson regression showed a significantly lower incidence rate ratio after supplementation [IRR = 0.139(0.098 to 0.199)]. The conditional Cox model revealed no immediate change in risk [HR = 10.858(0.725 to 162.663), p = 0.084] but a significant time-dependent protective effect [HR per log(day+1) = 0.381(0.160 to 0.911), p = 0.03], with the hazard ratio becoming protective by day 5 and reaching 0.32 (68% risk reduction) by day 28.
After propensity score matching, no significant difference in transfusion frequency was found between the ≤14-day and >14-day groups [median (IQR): 2 (1.5 to 3) vs. 2 (2 to 4), p = 0.544].
Source: ResultsAbstract: Conclusion
This study suggests an association between earlier vitamin AD supplementation and reduced transfusion needs in preterm infants, supported by a time-dependent protective effect. The specific optimal timing requires further prospective investigation.
Source: ConclusionAuthors’ abstract
Introduction
Anemia of prematurity (AOP) is a common condition, often necessitating transfusion therapy. Although vitamin AD deficiency has been linked to anemia pathogenesis, the effect of supplementation timing on transfusion needs remains unclear. This study investigates the association between the initiation timing of vitamin AD supplementation and the number of transfusions received in preterm infants.
Methods
In this retrospective cohort study, we included 226 preterm infants (gestational age <37 weeks) who received both blood transfusions and vitamin AD supplementation in a neonatal intensive care unit (2018 to 2022). The association was assessed using Spearman correlation. Segmented Poisson regression compared transfusion incidence rates before and after supplementation, controlling for hospitalization timeline. A conditional Cox model (Anderson-Gill) evaluated the impact on subsequent transfusion risk, adjusting for covariates. Patients were stratified by supplementation timing (≤14 vs. >14 days), with propensity score matching applied to balance groups.
Independent factors were identified using generalized linear models.
Results
The timing of vitamin AD initiation was positively correlated with transfusion number [Spearman’s ρ = 0.200(0.068 to 0.326), p = 0.003], an association that remained significant in subgroups including infants 28 to 37 weeks and those without complications. Multivariable analysis identified supplementation timing as an independent risk factor for transfusion frequency [β = 0.016(0.007 to 0.025), p < 0.001]. Segmented Poisson regression showed a significantly lower incidence rate ratio after supplementation [IRR = 0.139(0.098 to 0.199)]. The conditional Cox model revealed no immediate change in risk [HR = 10.858(0.725 to 162.663), p = 0.084] but a significant time-dependent protective effect [HR per log(day+1) = 0.381(0.160 to 0.911), p = 0.03], with the hazard ratio becoming protective by day 5 and reaching 0.32 (68% risk reduction) by day 28.
After propensity score matching, no significant difference in transfusion frequency was found between the ≤14-day and >14-day groups [median (IQR): 2 (1.5 to 3) vs. 2 (2 to 4), p = 0.544].
Conclusion
This study suggests an association between earlier vitamin AD supplementation and reduced transfusion needs in preterm infants, supported by a time-dependent protective effect. The specific optimal timing requires further prospective investigation.
Publication and source details
Original title: Early vitamin AD supplementation reduces transfusion needs in preterm infants: a retrospective cohort study
Futao Li; Xuhui Ye; Pan Tian; Ping Zhou; Xintian Shen
Frontiers in Nutrition · 2026
* Correspondence: Xintian Shen, homeostasis@163.com; Ping Zhou, xianggalao@126.comThese authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:35:08.309050+00:00
DOI: 10.3389/fnut.2026.1711120 · PMC13065723